Recombinant monoclonal antibody can specifically bind TPO outside the immunodominant region. This human anti-non-IDR antibody TF3.5 can be potentially used in the treatment of patients with TPO autoantibody-positive Graves.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-999 | Recombinant Anti-TPO Antibody | ELISA, WB, FuncS | IgG |
MHH-999 | Recombinant Human Anti-TPO Antibody | WB, ELISA, IHC, FuncS | IgG |
FAMAB-0364JF | Human Anti-TPO Recombinant Antibody (clone RI-34) | ELISA, FuncS | Human IgG |
FAMAB-1281CQ | Human Anti-TPO Recombinant Antibody (clone WR1.7) | ELISA, Inhib | Human IgE |
VS3-FY1477 | Recombinant Mouse Anti-TPO Antibody (clone 9G3-6F3-9B7) | IHC-P | Mouse IgG2b |
There are currently no Customer reviews or questions for FAMAB-0036JF-F(E). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.